 | • レポートコード：GIR201115629 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、過眠症治療薬の世界市場を調査対象にし、過眠症治療薬の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（プロビジル、ザイレム、その他）、用途別分析（病院薬局、小売薬局、オンライン薬局）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Teva、Fisher & Paykel Healthcare、AVADEL PHARMACEUTICALS、Jazz Pharmaceuticals、Theranexus、BIOPROJET、Merck、Pfizer、GlaxoSmithKline、Drive Medical ・企業別売上、市場シェア ・過眠症治療薬の地域別市場分析 ・過眠症治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・過眠症治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・過眠症治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・過眠症治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・過眠症治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・過眠症治療薬の種類別市場規模2015-2020：プロビジル、ザイレム、その他 ・過眠症治療薬の用途別市場規模2015-2020：病院薬局、小売薬局、オンライン薬局 ・過眠症治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Hypersomnia Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Hypersomnia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Hypersomnia Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Hypersomnia Drug market has been segmented into:
Provigil
Xyrem
Others
By Application, Hypersomnia Drug has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hypersomnia Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Hypersomnia Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hypersomnia Drug market.
The report offers in-depth assessment of the growth and other aspects of the Hypersomnia Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Hypersomnia Drug Market Share Analysis
Hypersomnia Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hypersomnia Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hypersomnia Drug sales, revenue and market share for each player covered in this report.
The major players covered in Hypersomnia Drug are:
Teva
Fisher & Paykel Healthcare
AVADEL PHARMACEUTICALS
Jazz Pharmaceuticals
Theranexus
BIOPROJET
Merck
Pfizer
GlaxoSmithKline
Drive Medical
Table of Contents
1 Hypersomnia Drug Market Overview
1.1 Product Overview and Scope of Hypersomnia Drug
1.2 Classification of Hypersomnia Drug by Type
1.2.1 Global Hypersomnia Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Hypersomnia Drug Revenue Market Share by Type in 2019
1.2.3 Provigil
1.2.4 Xyrem
1.2.5 Others
1.3 Global Hypersomnia Drug Market by Application
1.3.1 Overview: Global Hypersomnia Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Hypersomnia Drug Market by Regions
1.4.1 Global Hypersomnia Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Hypersomnia Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Hypersomnia Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Hypersomnia Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hypersomnia Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Hypersomnia Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hypersomnia Drug Status and Prospect (2015-2025)
2 Company Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Teva SWOT Analysis
2.1.4 Teva Product and Services
2.1.5 Teva Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Fisher & Paykel Healthcare
2.2.1 Fisher & Paykel Healthcare Details
2.2.2 Fisher & Paykel Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Fisher & Paykel Healthcare SWOT Analysis
2.2.4 Fisher & Paykel Healthcare Product and Services
2.2.5 Fisher & Paykel Healthcare Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 AVADEL PHARMACEUTICALS
2.3.1 AVADEL PHARMACEUTICALS Details
2.3.2 AVADEL PHARMACEUTICALS Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AVADEL PHARMACEUTICALS SWOT Analysis
2.3.4 AVADEL PHARMACEUTICALS Product and Services
2.3.5 AVADEL PHARMACEUTICALS Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Jazz Pharmaceuticals
2.4.1 Jazz Pharmaceuticals Details
2.4.2 Jazz Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Jazz Pharmaceuticals SWOT Analysis
2.4.4 Jazz Pharmaceuticals Product and Services
2.4.5 Jazz Pharmaceuticals Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Theranexus
2.5.1 Theranexus Details
2.5.2 Theranexus Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Theranexus SWOT Analysis
2.5.4 Theranexus Product and Services
2.5.5 Theranexus Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 BIOPROJET
2.6.1 BIOPROJET Details
2.6.2 BIOPROJET Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BIOPROJET SWOT Analysis
2.6.4 BIOPROJET Product and Services
2.6.5 BIOPROJET Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck SWOT Analysis
2.7.4 Merck Product and Services
2.7.5 Merck Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline SWOT Analysis
2.9.4 GlaxoSmithKline Product and Services
2.9.5 GlaxoSmithKline Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 Drive Medical
2.10.1 Drive Medical Details
2.10.2 Drive Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Drive Medical SWOT Analysis
2.10.4 Drive Medical Product and Services
2.10.5 Drive Medical Hypersomnia Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Hypersomnia Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Hypersomnia Drug Players Market Share
3.2.2 Top 10 Hypersomnia Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Hypersomnia Drug Revenue and Market Share by Regions
4.2 North America Hypersomnia Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Hypersomnia Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Hypersomnia Drug Revenue and Growth Rate (2015-2020)
4.5 South America Hypersomnia Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Hypersomnia Drug Revenue and Growth Rate (2015-2020)
5 North America Hypersomnia Drug Revenue by Countries
5.1 North America Hypersomnia Drug Revenue by Countries (2015-2020)
5.2 USA Hypersomnia Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Hypersomnia Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Hypersomnia Drug Revenue and Growth Rate (2015-2020)
6 Europe Hypersomnia Drug Revenue by Countries
6.1 Europe Hypersomnia Drug Revenue by Countries (2015-2020)
6.2 Germany Hypersomnia Drug Revenue and Growth Rate (2015-2020)
6.3 UK Hypersomnia Drug Revenue and Growth Rate (2015-2020)
6.4 France Hypersomnia Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Hypersomnia Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Hypersomnia Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Hypersomnia Drug Revenue by Countries
7.1 Asia-Pacific Hypersomnia Drug Revenue by Countries (2015-2020)
7.2 China Hypersomnia Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Hypersomnia Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Hypersomnia Drug Revenue and Growth Rate (2015-2020)
7.5 India Hypersomnia Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Hypersomnia Drug Revenue and Growth Rate (2015-2020)
8 South America Hypersomnia Drug Revenue by Countries
8.1 South America Hypersomnia Drug Revenue by Countries (2015-2020)
8.2 Brazil Hypersomnia Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Hypersomnia Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Hypersomnia Drug by Countries
9.1 Middle East & Africa Hypersomnia Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Hypersomnia Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Hypersomnia Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Hypersomnia Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Hypersomnia Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Hypersomnia Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Hypersomnia Drug Market Forecast by Type (2019-2024)
10.3 Provigil Revenue Growth Rate (2015-2025)
10.4 Xyrem Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Hypersomnia Drug Market Segment by Application
11.1 Global Hypersomnia Drug Revenue Market Share by Application (2015-2020)
11.2 Hypersomnia Drug Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Hypersomnia Drug Market Size Forecast (2021-2025)
12.1 Global Hypersomnia Drug Market Size Forecast (2021-2025)
12.2 Global Hypersomnia Drug Market Forecast by Regions (2021-2025)
12.3 North America Hypersomnia Drug Revenue Market Forecast (2021-2025)
12.4 Europe Hypersomnia Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Hypersomnia Drug Revenue Market Forecast (2021-2025)
12.6 South America Hypersomnia Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Hypersomnia Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Hypersomnia Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hypersomnia Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hypersomnia Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Hypersomnia Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Teva Corporate Information, Location and Competitors
Table 6. Teva Hypersomnia Drug Major Business
Table 7. Teva Hypersomnia Drug Total Revenue (USD Million) (2017-2018)
Table 8. Teva SWOT Analysis
Table 9. Teva Hypersomnia Drug Product and Solutions
Table 10. Teva Hypersomnia Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Fisher & Paykel Healthcare Corporate Information, Location and Competitors
Table 12. Fisher & Paykel Healthcare Hypersomnia Drug Major Business
Table 13. Fisher & Paykel Healthcare Hypersomnia Drug Total Revenue (USD Million) (2018-2019)
Table 14. Fisher & Paykel Healthcare SWOT Analysis
Table 15. Fisher & Paykel Healthcare Hypersomnia Drug Product and Solutions
Table 16. Fisher & Paykel Healthcare Hypersomnia Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. AVADEL PHARMACEUTICALS Corporate Information, Location and Competitors
Table 18. AVADEL PHARMACEUTICALS Hypersomnia Drug Major Business
Table 19. AVADEL PHARMACEUTICALS Hypersomnia Drug Total Revenue (USD Million) (2017-2018)
Table 20. AVADEL PHARMACEUTICALS SWOT Analysis
Table 21. AVADEL PHARMACEUTICALS Hypersomnia Drug Product and Solutions
Table 22. AVADEL PHARMACEUTICALS Hypersomnia Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Jazz Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Jazz Pharmaceuticals Hypersomnia Drug Major Business
Table 25. Jazz Pharmaceuticals Hypersomnia Drug Total Revenue (USD Million) (2017-2018)
Table 26. Jazz Pharmaceuticals SWOT Analysis
Table 27. Jazz Pharmaceuticals Hypersomnia Drug Product and Solutions
Table 28. Jazz Pharmaceuticals Hypersomnia Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Theranexus Corporate Information, Location and Competitors
Table 30. Theranexus Hypersomnia Drug Major Business
Table 31. Theranexus Hypersomnia Drug Total Revenue (USD Million) (2017-2018)
Table 32. Theranexus SWOT Analysis
Table 33. Theranexus Hypersomnia Drug Product and Solutions
Table 34. Theranexus Hypersomnia Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. BIOPROJET Corporate Information, Location and Competitors
Table 36. BIOPROJET Hypersomnia Drug Major Business
Table 37. BIOPROJET Hypersomnia Drug Total Revenue (USD Million) (2017-2018)
Table 38. BIOPROJET SWOT Analysis
Table 39. BIOPROJET Hypersomnia Drug Product and Solutions
Table 40. BIOPROJET Hypersomnia Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Merck Corporate Information, Location and Competitors
Table 42. Merck Hypersomnia Drug Major Business
Table 43. Merck Hypersomnia Drug Total Revenue (USD Million) (2017-2018)
Table 44. Merck SWOT Analysis
Table 45. Merck Hypersomnia Drug Product and Solutions
Table 46. Merck Hypersomnia Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Pfizer Corporate Information, Location and Competitors
Table 48. Pfizer Hypersomnia Drug Major Business
Table 49. Pfizer Hypersomnia Drug Total Revenue (USD Million) (2017-2018)
Table 50. Pfizer SWOT Analysis
Table 51. Pfizer Hypersomnia Drug Product and Solutions
Table 52. Pfizer Hypersomnia Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GlaxoSmithKline Corporate Information, Location and Competitors
Table 54. GlaxoSmithKline Hypersomnia Drug Major Business
Table 55. GlaxoSmithKline Hypersomnia Drug Total Revenue (USD Million) (2017-2018)
Table 56. GlaxoSmithKline SWOT Analysis
Table 57. GlaxoSmithKline Hypersomnia Drug Product and Solutions
Table 58. GlaxoSmithKline Hypersomnia Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Drive Medical Corporate Information, Location and Competitors
Table 60. Drive Medical Hypersomnia Drug Major Business
Table 61. Drive Medical Hypersomnia Drug Total Revenue (USD Million) (2017-2018)
Table 62. Drive Medical SWOT Analysis
Table 63. Drive Medical Hypersomnia Drug Product and Solutions
Table 64. Drive Medical Hypersomnia Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Hypersomnia Drug Revenue (Million USD) by Players (2015-2020)
Table 66. Global Hypersomnia Drug Revenue Share by Players (2015-2020)
Table 67. Global Hypersomnia Drug Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Hypersomnia Drug Revenue Market Share by Regions (2015-2020)
Table 69. North America Hypersomnia Drug Revenue by Countries (2015-2020)
Table 70. North America Hypersomnia Drug Revenue Market Share by Countries (2015-2020)
Table 71. Europe Hypersomnia Drug Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Hypersomnia Drug Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Hypersomnia Drug Revenue by Countries (2015-2020)
Table 74. South America Hypersomnia Drug Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Hypersomnia Drug Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Hypersomnia Drug Revenue Market Share by Countries (2015-2020)
Table 77. Global Hypersomnia Drug Revenue (Million USD) by Type (2015-2020)
Table 78. Global Hypersomnia Drug Revenue Share by Type (2015-2020)
Table 79. Global Hypersomnia Drug Revenue Forecast by Type (2021-2025)
Table 80. Global Hypersomnia Drug Revenue by Application (2015-2020)
Table 81. Global Hypersomnia Drug Revenue Share by Application (2015-2020)
Table 82. Global Hypersomnia Drug Revenue Forecast by Application (2021-2025)
Table 83. Global Hypersomnia Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Hypersomnia Drug Picture
Figure 2. Global Hypersomnia Drug Revenue Market Share by Type in 2019
Figure 3. Provigil Picture
Figure 4. Xyrem Picture
Figure 5. Others Picture
Figure 6. Hypersomnia Drug Revenue Market Share by Application in 2019
Figure 7. Hospital Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Online Pharmacies Picture
Figure 10. Global Hypersomnia Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Hypersomnia Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Hypersomnia Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Hypersomnia Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Hypersomnia Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Hypersomnia Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Hypersomnia Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Hypersomnia Drug Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Hypersomnia Drug Revenue Market Share in 2019
Figure 19. Global Top 10 Players Hypersomnia Drug Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Hypersomnia Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Hypersomnia Drug Revenue Market Share by Regions (2015-2020)
Figure 23. Global Hypersomnia Drug Revenue Market Share by Regions in 2018
Figure 24. North America Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 25. Europe Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 27. South America Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 29. North America Hypersomnia Drug Revenue Market Share by Countries (2015-2020)
Figure 30. North America Hypersomnia Drug Revenue Market Share by Countries in 2019
Figure 31. USA Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 32. Canada Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 34. Europe Hypersomnia Drug Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Hypersomnia Drug Revenue Market Share by Countries in 2019
Figure 36. Germany Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 37. UK Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 38. France Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 39. Russia Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 40. Italy Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Hypersomnia Drug Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Hypersomnia Drug Revenue Market Share by Countries in 2019
Figure 43. China Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 44. Japan Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 45. Korea Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 46. India Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 48. South America Hypersomnia Drug Revenue Market Share by Countries (2015-2020)
Figure 49. South America Hypersomnia Drug Revenue Market Share by Countries in 2019
Figure 50. Brazil Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Hypersomnia Drug Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Hypersomnia Drug Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 55. UAE Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Hypersomnia Drug Revenue and Growth Rate (2015-2020)
Figure 58. Global Hypersomnia Drug Revenue Share by Type (2015-2020)
Figure 59. Global Hypersomnia Drug Revenue Share by Type in 2019
Figure 60. Global Hypersomnia Drug Market Share Forecast by Type (2021-2025)
Figure 61. Global Provigil Revenue Growth Rate (2015-2020)
Figure 62. Global Xyrem Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Hypersomnia Drug Revenue Share by Application (2015-2020)
Figure 65. Global Hypersomnia Drug Revenue Share by Application in 2019
Figure 66. Global Hypersomnia Drug Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 68. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 69. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Hypersomnia Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Hypersomnia Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Hypersomnia Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Hypersomnia Drug Revenue Market Forecast (2021-2025)
Figure 74. Europe Hypersomnia Drug Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Hypersomnia Drug Revenue Market Forecast (2021-2025)
Figure 76. South America Hypersomnia Drug Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Hypersomnia Drug Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
小売用医薬品の世界市場 2020年 Market Overview The global Retail Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 1350.1 million by 2025, from USD 1211 million in 2019. The Retail Drug market report …- スニチニブ薬の世界市場 2020年 Market Overview The global Sunitinib Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sunitinib Drug market report p…
- CDK 4及び6阻害薬の世界市場 2020年 Market Overview The CDK 4 and 6 Inhibitor Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- アンブリセンタン薬の世界市場 2020年 Market Overview The global Ambrisentan Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ambrisentan Drug market repo…
- 甲状腺機能低下症治療の世界市場 2020年 Market Overview The global Hypothyroidism Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hypothyroidism Drug marke…